产品
name:3 Grass Mix
labeller:Alk Abello, Inc.
ndc-id:
ndc-product-code:0268-8001
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1975-01-15
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Subcutaneous
fda-application-number:BLA103753
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:8 Southern Grass Mix
labeller:Alk Abello, Inc.
ndc-id:
ndc-product-code:0268-8015
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1975-01-15
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Subcutaneous
fda-application-number:BLA103753
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:8 Southern Grass Mix
labeller:Alk Abello, Inc.
ndc-id:
ndc-product-code:0268-8016
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1975-01-15
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Subcutaneous
fda-application-number:BLA103753
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:9 Southern Grass Mix
labeller:Alk Abello, Inc.
ndc-id:
ndc-product-code:0268-8017
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1975-01-15
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Subcutaneous
fda-application-number:BLA103753
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Allergen Pack Johnson Grass
labeller:Alvix Laboratories
ndc-id:
ndc-product-code:15455-9011
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2015-07-20
ended-marketing-on:2018-03-08
dosage-form:Kit
strength:
route:Intradermal; Subcutaneous
fda-application-number:
generic:false
over-the-counter:false
approved:false
country:US
source:FDA NDC
name:Center-AL - Sorghum Halepense Pollen
labeller:ALK-Abello, Inc.
ndc-id:
ndc-product-code:0268-0087
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1975-01-15
ended-marketing-on:
dosage-form:Injection, suspension
strength:10000 [PNU]/1mL
route:Subcutaneous
fda-application-number:BLA103753
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Johnson Grass
labeller:Nelco Laboratories, Inc.
ndc-id:
ndc-product-code:36987-2330
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1972-08-29
ended-marketing-on:
dosage-form:Injection, solution
strength:10000 [PNU]/1mL
route:Intradermal; Subcutaneous
fda-application-number:BLA102192
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Johnson Grass
labeller:Nelco Laboratories, Inc.
ndc-id:
ndc-product-code:36987-2332
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1972-08-29
ended-marketing-on:
dosage-form:Injection, solution
strength:20000 [PNU]/1mL
route:Intradermal; Subcutaneous
fda-application-number:BLA102192
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Johnson Grass
labeller:Nelco Laboratories, Inc.
ndc-id:
ndc-product-code:36987-2334
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1972-08-29
ended-marketing-on:
dosage-form:Injection, solution
strength:0.05 g/1mL
route:Intradermal; Subcutaneous
fda-application-number:BLA102192
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Johnson Grass
labeller:Nelco Laboratories, Inc.
ndc-id:
ndc-product-code:36987-2333
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1972-08-29
ended-marketing-on:
dosage-form:Injection, solution
strength:40000 [PNU]/1mL
route:Intradermal; Subcutaneous
fda-application-number:BLA102192
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Johnson Grass
labeller:Nelco Laboratories, Inc.
ndc-id:
ndc-product-code:36987-2336
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1972-08-29
ended-marketing-on:
dosage-form:Injection, solution
strength:0.1 g/1mL
route:Intradermal; Subcutaneous
fda-application-number:BLA102192
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Johnson Grass
labeller:Nelco Laboratories, Inc.
ndc-id:
ndc-product-code:36987-2331
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1972-08-29
ended-marketing-on:
dosage-form:Injection, solution
strength:20000 [PNU]/1mL
route:Intradermal; Subcutaneous
fda-application-number:BLA102192
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Johnson Grass
labeller:Nelco Laboratories, Inc.
ndc-id:
ndc-product-code:36987-2335
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1972-08-29
ended-marketing-on:
dosage-form:Injection, solution
strength:0.05 g/1mL
route:Intradermal; Subcutaneous
fda-application-number:BLA102192
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Johnson Grass
labeller:Nelco Laboratories, Inc.
ndc-id:
ndc-product-code:36987-2329
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1972-08-29
ended-marketing-on:
dosage-form:Injection, solution
strength:10000 [PNU]/1mL
route:Intradermal; Subcutaneous
fda-application-number:BLA102192
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Johnson Grass
labeller:Greer Laboratories, Inc.
ndc-id:
ndc-product-code:22840-1215
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1981-09-15
ended-marketing-on:
dosage-form:Solution
strength:0.001 g/1mL
route:Intradermal; Percutaneous; Subcutaneous
fda-application-number:BLA101833
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Johnson Grass
labeller:Greer Laboratories, Inc.
ndc-id:
ndc-product-code:22840-5205
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1981-09-15
ended-marketing-on:
dosage-form:Solution
strength:0.05 g/1mL
route:Intradermal; Percutaneous; Subcutaneous
fda-application-number:BLA101833
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Johnson Grass
labeller:Greer Laboratories, Inc.
ndc-id:
ndc-product-code:22840-1243
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1981-09-15
ended-marketing-on:
dosage-form:Solution
strength:0.1 g/1mL
route:Intradermal; Percutaneous; Subcutaneous
fda-application-number:BLA101833
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Johnson Grass
labeller:Greer Laboratories, Inc.
ndc-id:
ndc-product-code:22840-1216
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1981-09-15
ended-marketing-on:
dosage-form:Solution
strength:1000 [PNU]/1mL
route:Intradermal; Percutaneous; Subcutaneous
fda-application-number:BLA101833
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Johnson Grass Pollen
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0275
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1992-04-13
ended-marketing-on:
dosage-form:Injection, solution
strength:0.1 g/1mL
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Johnson Grass Pollen
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0276
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1974-03-23
ended-marketing-on:
dosage-form:Injection, solution
strength:0.050 g/1mL
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Johnson Grass Pollen
labeller:Allergy Laboratories, Inc.
ndc-id:
ndc-product-code:54575-094
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1967-12-07
ended-marketing-on:
dosage-form:Injection, solution
strength:1 g/20mL
route:Percutaneous; Subcutaneous
fda-application-number:BLA101376
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Johnson Grass Pollen
labeller:Allermed Laboratories, Inc.
ndc-id:
ndc-product-code:49643-413
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1974-03-12
ended-marketing-on:
dosage-form:Injection
strength:0.05 g/1mL
route:Cutaneous; Intradermal; Subcutaneous
fda-application-number:BLA102211
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Mixture of Standardized and Non-Standardized Southern Grasses
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0239
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1997-06-13
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102226
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Mixture of Twenty-Two Standardized and Non-Standardized Grasses
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0240
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1997-06-13
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102226
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Number Fourteen Grass Mixture
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0238
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1997-06-13
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Pollens - Grasses, Grass Mix 8
labeller:Jubilant Hollisterstier Llc
ndc-id:
ndc-product-code:65044-0879
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1941-04-19
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Percutaneous; Subcutaneous
fda-application-number:BLA103888
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Pollens - Grasses, Johnson Grass Sorghum halepense
labeller:Jubilant Hollisterstier Llc
ndc-id:
ndc-product-code:65044-1746
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1941-04-19
ended-marketing-on:
dosage-form:Injection, solution
strength:500 [PNU]/1mL
route:Intradermal
fda-application-number:BLA103888
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Pollens - Grasses, Johnson Grass Sorghum halepense
labeller:Jubilant Hollisterstier Llc
ndc-id:
ndc-product-code:65044-1744
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1941-04-19
ended-marketing-on:
dosage-form:Injection, solution
strength:0.05 g/1mL
route:Percutaneous; Subcutaneous
fda-application-number:BLA103888
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Pollens - Grasses, Johnson Grass Sorghum halepense
labeller:Jubilant Hollisterstier Llc
ndc-id:
ndc-product-code:65044-1747
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1941-04-19
ended-marketing-on:
dosage-form:Injection, solution
strength:0.1 g/1mL
route:Percutaneous; Subcutaneous
fda-application-number:BLA103888
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Pollens - Grasses, Johnson Grass Sorghum halepense
labeller:Jubilant Hollisterstier Llc
ndc-id:
ndc-product-code:65044-1745
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1941-04-19
ended-marketing-on:
dosage-form:Injection, solution
strength:0.05 g/1mL
route:Percutaneous
fda-application-number:BLA103888
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Pollens - Grasses, Southern Grass Mix
labeller:Jubilant Hollisterstier Llc
ndc-id:
ndc-product-code:65044-0854
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1941-04-19
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Percutaneous; Subcutaneous
fda-application-number:BLA103888
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Pollens - Grasses, Southern Grass Mix
labeller:Jubilant Hollisterstier Llc
ndc-id:
ndc-product-code:65044-0856
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1941-04-19
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Percutaneous; Subcutaneous
fda-application-number:BLA103888
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Pollens - Grasses, Southern Grass Mix
labeller:Jubilant Hollisterstier Llc
ndc-id:
ndc-product-code:65044-0855
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1941-04-19
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Percutaneous
fda-application-number:BLA103888
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Pollens - Grasses, Southern Grass Mix
labeller:Jubilant Hollisterstier Llc
ndc-id:
ndc-product-code:65044-0857
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1941-04-19
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Percutaneous
fda-application-number:BLA103888
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Sorghum Halepense Pollen
labeller:ALK-Abello, Inc.
ndc-id:
ndc-product-code:0268-1214
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1965-01-01
ended-marketing-on:
dosage-form:Injection, solution
strength:0.10 g/1mL
route:Subcutaneous
fda-application-number:BLA103753
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Sorghum Halepense Pollen
labeller:ALK-Abello, Inc.
ndc-id:
ndc-product-code:0268-1215
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1965-01-01
ended-marketing-on:
dosage-form:Injection, solution
strength:0.05 g/1mL
route:Subcutaneous
fda-application-number:BLA103753
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Sorghum Halepense Pollen
labeller:ALK-Abello, Inc.
ndc-id:
ndc-product-code:0268-1216
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1965-01-01
ended-marketing-on:
dosage-form:Injection, solution
strength:40000 [PNU]/1mL
route:Subcutaneous
fda-application-number:BLA103753
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Sorghum Halepense Pollen
labeller:ALK-Abello, Inc.
ndc-id:
ndc-product-code:0268-1217
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1965-01-01
ended-marketing-on:
dosage-form:Injection, solution
strength:0.005 g/1mL
route:Subcutaneous
fda-application-number:BLA103753
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Sorghum Halepense Pollen
labeller:ALK-Abello, Inc.
ndc-id:
ndc-product-code:0268-1218
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1965-01-01
ended-marketing-on:
dosage-form:Injection, solution
strength:0.0005 g/1mL
route:Subcutaneous
fda-application-number:BLA103753
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Sorghum Halepense Pollen
labeller:ALK-Abello, Inc.
ndc-id:
ndc-product-code:0268-1219
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1965-01-01
ended-marketing-on:
dosage-form:Injection, solution
strength:10000 [PNU]/1mL
route:Subcutaneous
fda-application-number:BLA103753
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Sorghum Halepense Pollen
labeller:ALK-Abello, Inc.
ndc-id:
ndc-product-code:0268-1220
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1965-01-01
ended-marketing-on:
dosage-form:Injection, solution
strength:0.001 g/1mL
route:Subcutaneous
fda-application-number:BLA103753
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Sorghum Halepense Pollen
labeller:ALK-Abello, Inc.
ndc-id:
ndc-product-code:0268-6629
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1965-01-01
ended-marketing-on:
dosage-form:Injection, solution
strength:0.05 g/1mL
route:Percutaneous
fda-application-number:BLA103753
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Sorghum Halepense Pollen
labeller:ALK-Abello, Inc.
ndc-id:
ndc-product-code:0268-6717
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1965-01-01
ended-marketing-on:
dosage-form:Injection, solution
strength:1000 [PNU]/1mL
route:Intradermal
fda-application-number:BLA103753
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS128872
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0658
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS129085
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0676
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS329123
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0688
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS329151
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0716
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS329162
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0735
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS329197
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0726
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS329227
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0745
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS329240
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0763
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS329388
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0712
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS329678
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0656
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS329750
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0739
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS329802
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0682
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS329905
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0693
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS329915
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0732
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS330156
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0766
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS330170
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0687
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS330171
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0725
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2009-12-18
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS330317
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0684
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS330370
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0696
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS330376
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0705
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS330416
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0727
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS330453
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0711
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS330454
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0698
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS330503
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0738
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS330534
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0753
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS330583
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0699
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS330716
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0746
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS330718
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0662
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS330821
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0765
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS330928
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0722
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2009-12-18
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS331133
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0758
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS331153
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0715
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS331258
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0749
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS331327
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0713
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS331455
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0723
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2009-12-18
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS331621
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0724
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2009-12-18
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS331634
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0720
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS331794
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0751
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS331955
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0701
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS332080
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0702
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS332147
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0718
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS332287
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0761
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS332340
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0748
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS332343
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0729
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS332486
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0743
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS332509
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0695
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS332594
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0703
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS332679
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0768
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS332780
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0692
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS333177
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0742
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS333246
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0706
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS333308
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0691
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS333374
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0759
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS333375
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0764
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS333519
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0680
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS333743
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0681
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS333938
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0657
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS334128
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0772
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS334946
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0774
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS334972
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0776
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS335061
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0779
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS335101
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0778
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS335657
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0780
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS335823
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0782
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS336312
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0785
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS336437
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0786
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS336682
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0788
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS338909
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0796
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS339119
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0799
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS339185
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0801
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS339754
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0802
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS340054
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0806
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS340526
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0810
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS341430
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0814
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS341474
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0817
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS341824
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0818
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS343826
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0825
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS344001
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0826
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS344002
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0827
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS344004
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0829
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS344419
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0832
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS344421
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0834
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS344570
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0837
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS345049
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0841
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS345303
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0845
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS345380
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0846
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS345784
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0851
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS345825
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0852
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS346619
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0856
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS346752
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0860
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS346790
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0861
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS346877
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0864
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS346889
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0865
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS346963
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0867
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS346964
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0868
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS347115
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0869
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS347226
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0871
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS347227
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0872
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS347249
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0873
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS347335
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0875
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS347337
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0877
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS347338
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0878
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS347483
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0879
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS347628
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0884
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS347746
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0887
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS348283
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0889
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS348334
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0890
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS348402
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0892
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS348405
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0895
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS348467
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0896
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS348491
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0898
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2012-11-16
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS348562
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0900
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS348563
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0901
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS348982
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0904
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS349186
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0906
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS349291
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0911
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS349358
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0913
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS349573
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0914
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS349632
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0920
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS349779
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0923
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS349930
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0925
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS349931
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0926
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS349945
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0927
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS350093
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0928
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS350242
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0930
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS350257
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0932
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS350394
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0934
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS350534
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0935
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS350535
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0937
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS350566
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0939
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS350622
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0942
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS350906
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0945
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS351003
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0947
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS351031
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0949
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS351129
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0951
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS351142
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0952
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS351201
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0955
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS351312
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0957
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Treatment Set TS351315
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0960
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1986-10-31
ended-marketing-on:
dosage-form:Injection, solution
strength:
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
药物相互作用
DB00178The risk or severity of adverse effects can be increased when Ramipril is combined with Sorghum halepense pollen.
DB00492The risk or severity of adverse effects can be increased when Fosinopril is combined with Sorghum halepense pollen.
DB00519The risk or severity of adverse effects can be increased when Trandolapril is combined with Sorghum halepense pollen.
DB00542The risk or severity of adverse effects can be increased when Benazepril is combined with Sorghum halepense pollen.
DB00584The risk or severity of adverse effects can be increased when Enalapril is combined with Sorghum halepense pollen.
DB00691The risk or severity of adverse effects can be increased when Moexipril is combined with Sorghum halepense pollen.
DB00722The risk or severity of adverse effects can be increased when Lisinopril is combined with Sorghum halepense pollen.
DB00790The risk or severity of adverse effects can be increased when Perindopril is combined with Sorghum halepense pollen.
DB00881The risk or severity of adverse effects can be increased when Quinapril is combined with Sorghum halepense pollen.
DB00886The risk or severity of adverse effects can be increased when Omapatrilat is combined with Sorghum halepense pollen.
DB01180The risk or severity of adverse effects can be increased when Rescinnamine is combined with Sorghum halepense pollen.
DB01197The risk or severity of adverse effects can be increased when Captopril is combined with Sorghum halepense pollen.
DB01340The risk or severity of adverse effects can be increased when Cilazapril is combined with Sorghum halepense pollen.
DB01348The risk or severity of adverse effects can be increased when Spirapril is combined with Sorghum halepense pollen.
DB08836The risk or severity of adverse effects can be increased when Temocapril is combined with Sorghum halepense pollen.
DB09477The risk or severity of adverse effects can be increased when Enalaprilat is combined with Sorghum halepense pollen.
DB11783The risk or severity of adverse effects can be increased when Imidapril is combined with Sorghum halepense pollen.
DB13166The risk or severity of adverse effects can be increased when Zofenopril is combined with Sorghum halepense pollen.
DB13312The risk or severity of adverse effects can be increased when Delapril is combined with Sorghum halepense pollen.
DB14125The risk or severity of adverse effects can be increased when Benazeprilat is combined with Sorghum halepense pollen.
DB14207The risk or severity of adverse effects can be increased when Fosinoprilat is combined with Sorghum halepense pollen.
DB14208The risk or severity of adverse effects can be increased when Ramiprilat is combined with Sorghum halepense pollen.
DB14209The risk or severity of adverse effects can be increased when Trandolaprilat is combined with Sorghum halepense pollen.
DB14210The risk or severity of adverse effects can be increased when Moexiprilat is combined with Sorghum halepense pollen.
DB14213The risk or severity of adverse effects can be increased when Perindoprilat is combined with Sorghum halepense pollen.
DB14217The risk or severity of adverse effects can be increased when Quinaprilat is combined with Sorghum halepense pollen.
DB14231The risk or severity of adverse effects can be increased when Quinoline Yellow WS is combined with Sorghum halepense pollen.
DB15565The risk or severity of adverse effects can be increased when Cilazaprilat is combined with Sorghum halepense pollen.
DB00187The risk of a hypersensitivity reaction to Sorghum halepense pollen is increased when it is combined with Esmolol.
DB00195The risk of a hypersensitivity reaction to Sorghum halepense pollen is increased when it is combined with Betaxolol.
DB00264The risk of a hypersensitivity reaction to Sorghum halepense pollen is increased when it is combined with Metoprolol.
DB00335The risk of a hypersensitivity reaction to Sorghum halepense pollen is increased when it is combined with Atenolol.
DB00373The risk of a hypersensitivity reaction to Sorghum halepense pollen is increased when it is combined with Timolol.
DB00489The risk of a hypersensitivity reaction to Sorghum halepense pollen is increased when it is combined with Sotalol.
DB00571The risk of a hypersensitivity reaction to Sorghum halepense pollen is increased when it is combined with Propranolol.
DB00598The risk of a hypersensitivity reaction to Sorghum halepense pollen is increased when it is combined with Labetalol.
DB00612The risk of a hypersensitivity reaction to Sorghum halepense pollen is increased when it is combined with Bisoprolol.
DB00866The risk of a hypersensitivity reaction to Sorghum halepense pollen is increased when it is combined with Alprenolol.
DB00960The risk of a hypersensitivity reaction to Sorghum halepense pollen is increased when it is combined with Pindolol.
DB01136The risk of a hypersensitivity reaction to Sorghum halepense pollen is increased when it is combined with Carvedilol.
DB01182The risk of a hypersensitivity reaction to Sorghum halepense pollen is increased when it is combined with Propafenone.
DB01193The risk of a hypersensitivity reaction to Sorghum halepense pollen is increased when it is combined with Acebutolol.
DB01203The risk of a hypersensitivity reaction to Sorghum halepense pollen is increased when it is combined with Nadolol.
DB01295The risk of a hypersensitivity reaction to Sorghum halepense pollen is increased when it is combined with Bevantolol.
DB01297The risk of a hypersensitivity reaction to Sorghum halepense pollen is increased when it is combined with Practolol.
DB01359The risk of a hypersensitivity reaction to Sorghum halepense pollen is increased when it is combined with Penbutolol.
DB01580The risk of a hypersensitivity reaction to Sorghum halepense pollen is increased when it is combined with Oxprenolol.
DB03322The risk of a hypersensitivity reaction to Sorghum halepense pollen is increased when it is combined with Dexpropranolol.
DB04846The risk of a hypersensitivity reaction to Sorghum halepense pollen is increased when it is combined with Celiprolol.
DB04861The risk of a hypersensitivity reaction to Sorghum halepense pollen is increased when it is combined with Nebivolol.
DB06726The risk of a hypersensitivity reaction to Sorghum halepense pollen is increased when it is combined with Bufuralol.
DB08807The risk of a hypersensitivity reaction to Sorghum halepense pollen is increased when it is combined with Bopindolol.
DB08808The risk of a hypersensitivity reaction to Sorghum halepense pollen is increased when it is combined with Bupranolol.
DB08952The risk of a hypersensitivity reaction to Sorghum halepense pollen is increased when it is combined with Indenolol.
DB09204The risk of a hypersensitivity reaction to Sorghum halepense pollen is increased when it is combined with Arotinolol.
DB09351The risk of a hypersensitivity reaction to Sorghum halepense pollen is increased when it is combined with Levobetaxolol.
DB11770The risk of a hypersensitivity reaction to Sorghum halepense pollen is increased when it is combined with Talinolol.
DB11785The risk of a hypersensitivity reaction to Sorghum halepense pollen is increased when it is combined with Anisodamine.
DB12752The risk of a hypersensitivity reaction to Sorghum halepense pollen is increased when it is combined with Bucindolol.
DB13443The risk of a hypersensitivity reaction to Sorghum halepense pollen is increased when it is combined with Esatenolol.
DB13508The risk of a hypersensitivity reaction to Sorghum halepense pollen is increased when it is combined with Cloranolol.
DB13530The risk of a hypersensitivity reaction to Sorghum halepense pollen is increased when it is combined with Mepindolol.
DB13757The risk of a hypersensitivity reaction to Sorghum halepense pollen is increased when it is combined with Epanolol.
DB13775The risk of a hypersensitivity reaction to Sorghum halepense pollen is increased when it is combined with Tertatolol.
DB12212The risk of a hypersensitivity reaction to Sorghum halepense pollen is increased when it is combined with Landiolol.